首页 | 本学科首页   官方微博 | 高级检索  
检索        

IL-12基因联合吡柔比星治疗裸鼠膀胱癌移植瘤的实验
引用本文:王凤岐,赵维明,张诚,金承俊,张子健,钟照华,修有成.IL-12基因联合吡柔比星治疗裸鼠膀胱癌移植瘤的实验[J].肿瘤防治研究,2010,37(11):1241-1244.
作者姓名:王凤岐  赵维明  张诚  金承俊  张子健  钟照华  修有成
作者单位:1.150010 哈尔滨,哈尔滨医科大学附属第一医院泌尿外科;2.哈尔滨医科大学基础医学院微生物教研室
基金项目:哈尔滨市培养学科后备带头人基金资助项目,哈尔滨市科技创新人才研究专项资金资助项目
摘    要:目的 探讨联合应用白细胞介素12(IL-12)质粒和吡柔比星(THP)对人膀胱癌裸鼠移植瘤生长的抑制作用。方法 将人EJ膀胱癌细胞株裸鼠腋下接种,成瘤后设4组(每组6只):联合组于骨骼肌注射IL-12真核表达质粒pcAGGS-mIL-12和腹腔注射THP;IL-12组骨骼肌注射pcAGGS-mIL-12;THP组腹腔注射THP;对照组肌肉及腹腔注射0.9%氯化钠溶液,以上注射每周2次,共4次。观察各组裸鼠肿瘤大小变化。4周后处死荷瘤鼠。免疫组织化学法检测肿瘤内VEGF 表达。ELISA法测定血液及肿瘤组织中IL-12和γ-干扰素(IFN-γ)的表达。结果 联合组肿瘤生长明显抑制,瘤重及体积明显小于其他组。ELISA法表明IL-12组和联合组 IL-12和IFN-γ都高表达。免疫组织化学法表明联合组VEGF基因表达量明显低于其他组(P<0.05)。结论 联合应用IL-12真核表达质粒pCAGGS-mIL-12和THP,对人膀胱癌裸鼠移植瘤的抑制作用明显强于单独应用IL-12和THP。

关 键 词:膀胱癌  白细胞介素-12  吡柔比星  基因治疗  
收稿时间:2009-9-24
修稿时间:2010-3-16

Experimental of Combining Therapy with IL-12 Gene and THP in Bladder Cancer Nude Mice Model
WANG Feng-qi,ZHAO Wei-ming,ZHANG Cheng,JIN Cheng-jun,ZHANG Zi-jian,ZHONG Zhao-hua,XIU You-cheng.Experimental of Combining Therapy with IL-12 Gene and THP in Bladder Cancer Nude Mice Model[J].Cancer Research on Prevention and Treatment,2010,37(11):1241-1244.
Authors:WANG Feng-qi  ZHAO Wei-ming  ZHANG Cheng  JIN Cheng-jun  ZHANG Zi-jian  ZHONG Zhao-hua  XIU You-cheng
Institution:1.Department of Urology,The First Hospital of Harbin Medical University,Harbin 150010,China;2. Department of Microbiology,Harbin Medical University
Abstract:ObjectiveTo explore the inhibition of mouse interleukin-12 (IL-12) gene and THP on bladder cancer nude mice model.Methods After subcutaneous injection of EJ human bladder tumor cells to the nude mice subaxillary,Nude mice were divided into four groups randomly(Combine,IL-12,THP and control groups).Nude mice in Combine group were injected plasmid pCAGGS-mIL-12 on skeletal muscle and THP peritoneally.IL-12 group only were injected plasmid pCAGGS-mIL-12 on skeletal muscle; THP group were injected THP peritoneally; Control group were injected saline peritoneally and on skeletal muscle.All injections were carried two times per week for two weeks.The expression of IL-12 and IFN-γ in blood was assayed by an enzyme linked immunosorbent assay (ELISA)at one week after injection.Mice were sacrificed at fourth week.The level of VEGF in tumor tissue was detected by immunohistochemistry.IL-12 and IFN-γ in tumor tissue was assayed by ELISA. Results In combine group,tumor growth were retarded compared with the other groups.There was a significantly low expression of VEGF in the combined group; IL-12 and IFN-γ were increased in both the IL-12 group and combined group.Conclusion Both injected pCAGGS-mIL-12 on skeletal muscle and THP peritoneally could inhibit the xenograft in nude mice planted with human bladder tumor cells.
Keywords:Bladder cancer  IL-12 gene  THP  Gene therapy
本文献已被 万方数据 等数据库收录!
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号